The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Impaired Cerebral Cortical Gray Matter Growth After Treatment With Dexamethasone for Neonatal Chronic Lung Disease
Abstract
Objective.: The specific aim of this study was to quantify at term the influence of postnatal systemic dexamethasone treatment for neonatal chronic lung disease on subsequent brain growth and development in premature infants without evidence of severe intraventricular hemorrhage or white matter injury. Methods.: Eighteen premature (23 to 31 weeks) infants, 7 treated with dexamethasone and 11 not treated, were studied at term, ie, 38 to 41 postconceptional weeks, by an advanced quantitative volumetric 3-dimensional magnetic resonance imaging (MRI) technique to quantify cerebral tissue volumes. Fourteen healthy term infants also were studied for comparison. A sequence of image processing algorithms was used to segment each of the MRI slices into the following separate tissue classes: cerebral cortical gray matter, basal ganglia/thalami, unmyelinated white matter, myelinated white matter, and cerebrospinal fluid, all classified based on magnetic resonance signal intensity and anatomic location. A final summing of voxels for each tissue class was performed to compute absolute volumes in milliliters. Results.: Cerebral cortical gray matter volume in premature infants treated with dexamethasone was reduced 35% when compared with gray matter volume in premature infants not treated with dexamethasone (mean ± standard deviation, 130.3 ± 54.0 vs 200.6 ± 35.1 mL, respectively). Subcortical gray matter volumes (basal ganglia and thalami) and myelinated and unmyelinated white matter volumes were not significantly different among the treated and untreated groups. However, premature infants treated with dexamethasone exhibited a reduction (30%) in total cerebral tissue volume compared with total cerebral tissue volume in both the premature infants not treated with dexamethasone and the control term infants (312.7 ± 43.7 vs 448.2 ± 50.2 and 471.6 ± 36.4 mL respectively). This latter finding relates primarily to the decrease in cerebral cortical gray matter volume. Conclusions.: The data suggest an impairment in brain growth, principally affecting cerebral cortical gray matter, secondary to systemic dexamethasone therapy. Although the premature infants who received dexamethasone were smaller with more severe respiratory disease, these findings are consistent with growing evidence of a potential deleterious effect of dexamethasone on neonatal brain and subsequent neurodevelopmental outcome. This apparent deleterious effect should be taken into consideration by clinicians when weighing the potential risks and benefits of this therapy for low birth weight infants with neonatal chronic lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Neonatal Network (1993) · The Lancet · doi:10.1016/0140-6736(93)92296-6 · Cited by 773
Outcomes of children of extremely low birthweight and gestational age in the 1990's
Hack, M., & Fanaroff, A. A. (1999) · Early Human Development · doi:10.1016/s0378-3782(98)00052-8 · Cited by 695
Quantitative magnetic resonance imaging of brain development in premature and mature newborns
Hüppi, P. S., Warfield, S., Kikinis, R., Barnes, P. D., Zientara, G. P., Jolesz, F. A., Tsuji, M. K., & Volpe, J. J. (1998) · Annals of Neurology · doi:10.1002/ana.410430213 · Cited by 692
Self-citationBrain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
Uno, H., Lohmiller, L., Thieme, C., Kemnitz, J. W., Engle, M. J., Roecker, E. B., & Farrell, P. M. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90002-g · Cited by 502
A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia
Cummings, J. J., D'Eugenio, D. B., & Gross, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202301 · Cited by 483
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Yeh, T. F., Lin, Y. J., Huang, C. C., Chen, Y. J., Lin, C. H., Lin, H. C., Hsieh, W. S., & Lien, Y. J. (1998) · Pediatrics · doi:10.1542/peds.101.5.e7 · Cited by 418
O'Shea, T. M., Kothadia, J. M., Klinepeter, K. L., Goldstein, D. J., Jackson, B. G., Weaver, R. G., & Dillard, I. A. R. G. (1999) · Pediatrics · doi:10.1542/peds.104.1.15 · Cited by 376
Repeated Prenatal Corticosteroids Delay Myelination in the Ovine Central Nervous System
Dunlop, S. A., Archer, M. A., Quinlivan, J. A., Beazley, L. D., & Newnham, J. P. (1997) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1002/(sici)1520-6661(199711/12)6:6<309::aid-mfm1>3.0.co;2-s · Cited by 240
Brain injury in the premature infant: Overview of clinical aspects, neuropathology, and pathogenesis
Volpe, J. J. (1998) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(98)80030-2 · Cited by 221
Self-citationA Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants
Papile, L.-A., Tyson, J. E., Stoll, B. J., Wright, L. L., Donovan, E. F., Bauer, C. R., Krause-Steinrauf, H., Verter, J., Korones, S. B., Lemons, J. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381604 · Cited by 172
Cited by
Warfield, S. K., Zou, K. H., & Wells, W. M. (2004) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2004.828354 · Cited by 2,072
Self-citationNeonatal MRI to Predict Neurodevelopmental Outcomes in Preterm Infants
Woodward, L. J., Anderson, P. J., Austin, N. C., Howard, K., & Inder, T. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053792 · Cited by 1,348
Self-citationNeurobiology of Periventricular Leukomalacia in the Premature Infant
Volpe, J. J. (2001) · Pediatric Research · doi:10.1203/00006450-200111000-00003 · Cited by 948
Self-citationAbnormal Cerebral Structure Is Present at Term in Premature Infants
Inder, T. E., Warfield, S. K., Wang, H., Hüppi, P. S., & Volpe, J. J. (2005) · Pediatrics · doi:10.1542/peds.2004-0326 · Cited by 885
Self-citationProcedural pain and brain development in premature newborns
Brummelte, S., Grunau, R. E., Chau, V., Poskitt, K. J., Brant, R., Vinall, J., Gover, A., Synnes, A. R., & Miller, S. P. (2012) · Annals of Neurology · doi:10.1002/ana.22267 · Cited by 737
Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., & Tsai, C. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032089 · Cited by 596
Inder, T. E., Wells, S. J., Mogridge, N. B., Spencer, C., & Volpe, J. J. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00357-3 · Cited by 521
Self-citationGrunau, R. E., Whitfield, M. F., Petrie-Thomas, J., Synnes, A. R., Cepeda, I. L., Keidar, A., Rogers, M., MacKay, M., Hubber-Richard, P., & Johannesen, D. (2009) · Pain · doi:10.1016/j.pain.2009.02.014 · Cited by 502
Cerebellum of the Premature Infant: Rapidly Developing, Vulnerable, Clinically Important
Volpe, J. J. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338067 · Cited by 503
Self-citationTolsa, C. B., Zimine, S., Warfield, S. K., Freschi, M., Rossignol, A. S., Lazeyras, F., Hanquinet, S., Pfizenmaier, M., & Hüppi, P. S. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000128983.54614.7e · Cited by 484
Self-citationNew MR Imaging Assessment Tool to Define Brain Abnormalities in Very Preterm Infants at Term
Kidokoro, H., Neil, J. J., & Inder, T. E. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3521 · Cited by 473
Self-citationRegional Brain Volumes and Their Later Neurodevelopmental Correlates in Term and Preterm Infants
Peterson, B. S., Anderson, A. W., Ehrenkranz, R., Staib, L. H., Tageldin, M., Colson, E., Gore, J. C., Duncan, C. C., Makuch, R., & Ment, L. R. (2003) · Pediatrics · doi:10.1542/peds.111.5.939 · Cited by 451
Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants
Committee on Fetus and Newborn (2002) · Pediatrics · doi:10.1542/peds.109.2.330 · Cited by 442
Counsell, S. J., Allsop, J. M., Harrison, M. C., Larkman, D. J., Kennea, N. L., Kapellou, O., Cowan, F. M., Hajnal, J. V., Edwards, A. D., & Rutherford, M. A. (2003) · Pediatrics · doi:10.1542/peds.112.1.1 · Cited by 401
Brain Injury and Altered Brain Growth in Preterm Infants: Predictors and Prognosis
Kidokoro, H., Anderson, P. J., Doyle, L. W., Woodward, L. J., Neil, J. J., & Inder, T. E. (2014) · Pediatrics · doi:10.1542/peds.2013-2336 · Cited by 395
Self-citationBruckner, A. L., & Frieden, I. J. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.200 · Cited by 381
Perinatal risk factors altering regional brain structure in the preterm infant
Thompson, D. K., Warfield, S. K., Carlin, J. B., Pavlovic, M., Wang, H. X., Bear, M., Kean, M. J., Doyle, L. W., Egan, G. F., & Inder, T. E. (2007) · Brain · doi:10.1093/brain/awl277 · Cited by 320
Self-citationDavis, J. M., Parad, R. B., Michele, T., Allred, E., Price, A., Rosenfeld, W., & for the North American Recombinant Human CuZnSOD Study Group (2003) · Pediatrics · doi:10.1542/peds.111.3.469 · Cited by 268
Preterm Infants as Young Adults: A Swedish National Cohort Study
Lindström, K., Winbladh, B., Haglund, B., & Hjern, A. (2007) · Pediatrics · doi:10.1542/peds.2006-3260 · Cited by 252
Potential programming of dopaminergic circuits by early life stress
Rodrigues, A.-J., Leão, P., Carvalho, M., Almeida, O. F. X., & Sousa, N. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2085-3 · Cited by 97
Exogenous glucocorticoids and adverse cerebral effects in children
Damsted, S. K., Born, A. P., Paulson, O. B., & Uldall, P. (2011) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2011.05.002 · Cited by 51
Corticosteroids in the prevention and management of bronchopulmonary dysplasia
Grier, D. G., & Halliday, H. L. (2003) · Seminars in Neonatology · doi:10.1016/s1084-2756(02)00189-6 · Cited by 51
Brain growth in the NICU: critical periods of tissue-specific expansion
Matthews, L. G., Walsh, B. H., Knutsen, C., Neil, J. J., Smyser, C. D., Rogers, C. E., & Inder, T. E. (2018) · Pediatric Research · doi:10.1038/pr.2018.4 · Cited by 48
Self-citationFeng, Y., Rhodes, P. G., Liu, H., & Bhatt, A. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.024 · Cited by 29
Metadata
- Authors
- Murphy, B. P., Inder, T. E., Huppi, P. S., Warfield, S., Zientara, G. P., Kikinis, R., Jolesz, F. A., & Volpe, J. J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2001-02-01
- Volume
- 107
- Issue
- 2
- Pages
- 217-221
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2068515283
- Cited by
- 369
- References
- 20
- FWCI
- 31.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.